Pfizer Stock News

Biological weapons are microorganisms like virus, bacteria, fungi, or other toxins that are produced and released deliberately to cause disease and death in humans. Pfizer-BioNtech COVID-19 mRNA vaccines contain a number of toxins that poses serious health risks. Toxins can be small molecules, peptides, or proteins that are capable of causing disease on contact with or absorption by body tissues interacting with []

Related Stocks: MDU , LHX , BMY , RDS.A , TFI , SIVR , LLY , SPY , HD , PFE , WMT ,

Regulators are set to clear extra doses of Pfizer-BioNTechs vaccine as soon as Thursday, after states began expanding eligibility on their own.

The antiviral drugs have helped inspire hope among senior administration officials that the United States will be able to curb the devastating toll from the Delta variant.

NEW YORK (AP) An influential U.S. advisory panel will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday, a move that could make the shots available nationwide as early as this weekend. Some cities and states already allow all adults to get boosters of Pfizers vaccine, but it is not yet

WASHINGTON: Pfizer, BioNTech and Moderna are making combined profits of $65,000 every minute from their highly successful Covid-19 vaccines while the worlds poorest countries remain largely unvaccinated, according to a new analysis. The companies have sold the vast majority of their doses to rich countries, leaving low-income nations in the lurch, said the Peoples Vaccine Alliance (PVA), a coalition campaigning for wider access to Covid vaccines, which based its calculations on the firms own earning reports. The Alliance estimates that the trio will make pre-tax profits of $34 billion this year between them, which works out to over $1,000 a second, $65,000 a minute or $93.5 million a day. It is obscene that just a few companies are making millions of dollars in profit every single hour, while just two percent of people in low-income countries have been fully vaccinated against coronavirus, Maaza Seyoum of the African Alliance and Peoples Vaccine Alliance Africa said. Pfizer, BioNTech and Moderna have used their monopolies to prioritise the most profitable contracts with the richest governments, leaving low-income countries out in the cold. Pfizer and BioNTech have delivered less than one percent of their total supplies to low-income countries while Moderna has delivered just 0.2 percent, the PVA said.

The FDA is planning to authorize booster doses of Pfizer-BioNTech''s COVID-19 vaccine for all adults aged 18 and older as early as Thursday, according to a report from The New York Times.

The oral drug could be a promising new weapon in the fight against the pandemic, as it can be taken as an early at-home treatment.

The White House will reportedly announce the deal later this week. Costing about $500 per treatment, the federal government is expected to pay Pfizer about $5 billion for the game-changing pill.

Pfizer announced on Tuesday it is asking federal regulators to authorize its experimental antiviral COVID-19 pill and the Biden administration plans to purchase 10 million doses, according to a source familiar with the plans.

The company conducted trials with unvaccinated people who were high-risk, due to age or health issues, who were showing early symptoms of COVID-19 infection.

(Bloomberg) -- The Biden administration plans to buy enough of Pfizer Inc.s new Covid-19 pill to treat 10 million patients, people familiar with the matter say.

(RTTNews) - Pfizer Inc. (PFE) on Tuesday submitted an application to the U.S. Food and Drug Administration for emergency authorization of its investigational Covid-19 treatment pill. Pfizer said it is seeking Emergency Use Authorization (EUA) of its investigational oral antiviral candidate, PAXLOVID for the treatment of mild to moderate